Bevacizumab for the Treatment of Non-Resectable Pseudomyxoma peritonei Associated with Mucinous Ovarian Tumor of Low Malignant Potential - A Comparison of Two Cases.
作者： Ira Winer , Ronald J. Buckanovich
DOI: 10.1159/000270179
关键词:
摘要: Pseudomyxoma peritonei (PMP) is a rare tumor syndrome that can be diagnosed in association with mucinous ovarian tumors of low malignant potential. Surgical debulking the primary treatment modality
karger.com
sci-hub.se 参考文章(14)
A L Farquharson, N Pranesh, G Witham, R Swindell, M B Taylor, A G Renehan, S Rout, M S Wilson, S T O'Dwyer, M P Saunders, A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei. British Journal of Cancer. ,vol. 99, pp. 591- 596 ,(2008) , 10.1038/SJ.BJC.6604522
Brigitte M. Ronnett, Jeffrey D. Seidman, Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. The American Journal of Surgical Pathology. ,vol. 27, pp. 650- 657 ,(2003) , 10.1097/00000478-200305000-00008
Stanley B. Kaye, Bevacizumab for the treatment of epithelial ovarian cancer: will this be its finest hour? Journal of Clinical Oncology. ,vol. 25, pp. 5150- 5152 ,(2007) , 10.1200/JCO.2007.13.6150
Cheng H. Lo, Rob D. Bohmer, Penny I. Blomfield, AN EVIDENCE-BASED APPROACH: SUGARBAKER PROTOCOL AND PSEUDOMYXOMA PERITONEI OF APPENDICEAL ORIGIN ANZ Journal of Surgery. ,vol. 78, pp. 327- 328 ,(2008) , 10.1111/J.1445-2197.2008.04462.X
Brigitte M Ronnett, Robert J Kurman, Christopher M Zahn, Barry M Shmookler, Kathleen A Jablonski, Mary E Kass, Paul H Sugarbaker, Pseudomyxoma peritonei in women: A clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential Human Pathology. ,vol. 26, pp. 509- 524 ,(1995) , 10.1016/0046-8177(95)90247-3
Naureen Starling, David Cunningham, Monoclonal antibodies against vascular endothelial growth factor and epidermal growth factor receptor in advanced colorectal cancers: present and future directions. Current Opinion in Oncology. ,vol. 16, pp. 385- 390 ,(2004) , 10.1097/01.CCO.0000128278.15371.E4
Christine Szych, Annette Staebler, Denise C. Connolly, Rong Wu, Kathleen R. Cho, Brigitte M. Ronnett, Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women American Journal of Pathology. ,vol. 154, pp. 1849- 1855 ,(1999) , 10.1016/S0002-9440(10)65442-9
Robert M. Smeenk, Vic J. Verwaal, Ninja Antonini, Frans A. N. Zoetmulder, Progression of Pseudomyxoma Peritonei after Combined Modality Treatment: Management and Outcome Annals of Surgical Oncology. ,vol. 14, pp. 493- 499 ,(2007) , 10.1245/S10434-006-9174-X
David M. Sherer, Ovadia Abulafia, Rami Eliakim, Pseudomyxoma peritonei: a review of current literature. Gynecologic and Obstetric Investigation. ,vol. 51, pp. 73- 80 ,(2001) , 10.1159/000052897
Lewin Eisele, Sien-Yi Sheu, Hannes Müller-Beißenhirtz, Anja Welt, Siegfried Seeber, Response of Pseudomyxoma Peritonei to Gemcitabine Acta Oncologica. ,vol. 45, pp. 98- 100 ,(2006) , 10.1080/02841860500341165